Obstacles to cheaper and cheaper sequencing are falling by the wayside, writes Eilene Zimmerman at CNN Money. She notes that when James Watson had his genome sequenced by 454 in 2007, it cost about $1 million, but newer technologies are bringing that cost drastically down.

"The cost-per-bit of biologic information is coming down faster than Moore's Law," Steven Burrill, from the financial services firm Burrill & Company tells her.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.